Carl Djerassi, father of birth control pill passes away at 91
Djerassi, A Professor Emeritus Of Chemistry At Stanford, Was Most Famous For Leading A Research Team In Mexico City That In 1951 Developed Norethindrone, A Synthetic Molecule That Became A Key Component Of The First Birth Control Pill.
Carl Djerassi, the chemist widely considered the father of the birth control pill, has died.
Djerrasi died of complications of cancer in his San Francisco home, Stanford University spokesman Dan Stober said. He was 91.
Djerassi, a professor emeritus of chemistry at Stanford, was most famous for leading a research team in Mexico City that in 1951 developed norethindrone, a synthetic molecule that became a key component of the first birth control pill.
“The pill,” as it came to be known, radically transformed sexual practices and women’s lives.
In his book, “This Man’s Pill,” Djerassi said the invention also changed his life, making him more interested in how science affects society.
In 1969, he submitted a public policy article about the global implications of US contraceptive research, according to the Stanford News Service. In 1970, he published another article about the feasibility of a birth control pill for men.
“The thoughts behind these two public policy articles had convinced me that politics, rather than science, would play the dominant role in shaping the future of human birth control,” he wrote.
He is survived by a son, Dale Djerassi; a stepdaughter, Leah Middlebrook; and a grandson, Alexander M Djerassi.
For all the Latest World News, Download News Nation Android and iOS Mobile Apps.
More from World
EUFSC President Konstantin Ishkhanov “Thrilled†to Announce Opening of InClassica Festival in Dubai
Maiden Al-Mohed Al-Hindi Exercise Set to Begin Between Indian Navy and Saudi Arabia Navy
Excellent job by India in reducing COVID-19 related deaths by clamping lockdown: Indian-American doc
Pak summons Indian diplomat over expulsion of 2 High Commission officials on espionage charges
Trump postpones G7 summit, wants India, others to join group